<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>Bergenia ciliata</italic> rhizome extracts (MeOH and aqueous) were tested for their cytotoxicity on human breast, liver, and prostate cancer cell-lines by XTT assay, respectively. Both the extracts exhibited concentration-dependent toxicity in each of three cell lines [
 <xref rid="B156-molecules-25-05555" ref-type="bibr">156</xref>]. The IC
 <sub>50</sub> value of both extracts fell within the acceptable range in all cell-lines (except Hep 3B cell-lines). Thus, Bergenias possess potential antineoplastic activity that may have probable clinical use as preventive medicine [
 <xref rid="B76-molecules-25-05555" ref-type="bibr">76</xref>,
 <xref rid="B77-molecules-25-05555" ref-type="bibr">77</xref>].
</p>
